Postoperative outcomes in patients with hepatocellular carcinomas resected with exposure of the tumor surface: Clinical role of the no-margin resection

Archives of Surgery

Volumn 142, Issue 7, 2007, Pages 596-602

  Matsui, Yoichi ^a   Terakawa, Naoyoshi ^a   Satoi, Sohei ^a   Kaibori, Masaki ^a   Kitade, Hiroaki ^a   Takai, Soichiro ^a   Kwon, A Hon ^a   Kamiyama, Yasuo ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; HUMAN; LIVER CELL CARCINOMA; LIVER RESECTION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; TREATMENT OUTCOME;

AGED; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; CARCINOMA, HEPATOCELLULAR; COHORT STUDIES; DISEASE-FREE SURVIVAL; ELECTROCOAGULATION; FEMALE; FOLLOW-UP STUDIES; HEPATECTOMY; HUMANS; LIVER; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME;

EID: 34447504699     PISSN: 00040010     EISSN: 15383644     Source Type: Journal    
DOI: 10.1001/archsurg.142.7.596     Document Type: Article

References (39)

1. Yamanaka N, Okamoto E, Toyosaka A, et al. Prognostic factors after hepatectomy for hepatocellular carcinomas: a univariate and multivariate analysis. Cancer. 1990;65(5):1104-1110.
2. Sugioka A, Tsuzuki T, Kanai T. Postresection prognosis of patients with hepatocellular carcinoma. Surgery. 1993;113(6):612-618.
3. Chen M-F, Hwang TL, Jeng LB, Wang C-S, Jan Y-Y, Chen S-C. Postoperative recurrence of hepatocellular carcinoma. Arch Surg. 1994;129(7):738-742.
4. Nonami T, Harada A, Kurokawa T, Nakao A, Takagi H. Hepatic resection for hepatocellular carcinoma. Am J Surg. 1997;173(4):288-291.
5. Chau GY, Lui WY, Tsay SH, et al. Prognostic significance of surgical margin in hepatocellular carcinoma resection: an analysis of 165 Childs' A patients. J Surg Oncol. 1997;66(2):122-126.
6. Lau H, Fan ST, Ng IO, Wong J. Long term prognosis after hepatectomy for hepatocellular carcinoma: a survival analysis of 204 consecutive patients. Cancer. 1998;83(11):2302-2311.
7. Yamamoto M, Takasaki K, Ohtsubo T, Katsuragawa H, Fukuda C, Katagiri S. Effectiveness of systematized hepatectomy with Glisson's pedicle transection at the hepatic hilus for small nodular hepatocellular carcinoma: retrospective analysis. Surgery. 2001;130(3):443-448.
8. Regimbeau JM, Kianmanesh R, Farges O, Dondero F, Sauvanet A, Belghiti J. Extent of liver resection influences the outcome in patients with cirrhosis and small hepatocellular carcinoma. Surgery. 2002;131(3):311-317.
9. Matsumata T, Kanematsu T, Takenaka K, Yoshida Y, Nishizaki T, Sugimachi K. Patterns of intrahepatic recurrence after curative resection hepatocellular carcinoma. Hepatology. 1989;9(3):457-460.
10. Yoshida Y, Kanematsu T, Matsumata T, Takenaka K, Sugimachi K. Surgical margin and recurrence after resection of hepatocellular carcinoma in patients with cirrhosis: further evaluation of limited hepatic resection. Ann Surg. 1989;209 (3):297-301.
11. Shirabe K, Kanematsu T, Matsumata T, Adachi E, Akazawa K, Sugimachi K. Factors linked to early recurrence of small hepatocellular carcinoma after hepatectomy: univariate and multivariate analyses. Hepatology. 1991;14(5):802-805.
12. Jwo SC, Chiu JH, Chau GY, Loong CC, Lui WY. Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection. Hepatology. 1992;16(6):1367-1371.
13. Izumi R, Shimizu K, Ii T, et al. Prognostic factors of hepatocellular carcinoma in patients undergoing hepatic resection. Gastroenterology. 1994;106(3):720-727.
14. Adachi E, Maeda T, Matsumata T, et al. Risk factors for intrahepatic recurrence in human small hepatocellular carcinoma. Gastroenterology. 1995;108(3):768-775.
15. Ko S, Nakajima Y, Kanehiro H, et al. Significant influence of accompanying chronic hepatitis status on recurrence of hepatocellular carcinoma after hepatectomy: result of multivariate analysis. Ann Surg. 1996;224(5):591-595.
16. Yamamoto J, Kosuge T, Takayama T, et al. Recurrence of hepatocellular carcinoma after surgery. Br J Surg. 1996;83(9):1219-1222.
17. Ochiai T, Takayama T, Inoue K, et al. Hepatic resection with and without surgical margins for hepatocellular carcinoma in patients with impaired liver function. Hepatogastroenterology. 1999;46(27):1885-1889.
18. Poon RT-P, Fan S-T, Ng IO-L, Wong J. Significance of resection margin in hepatectomy for hepatocellular carcinoma. Ann Surg. 2000;231(4):544-551.
19. Ko S, Kanehiro H, Hisanaga M, Nagao M, Ikeda N, Nakajima Y. Liver fibrosis increases the risk of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. Br J Surg. 2002;89(1):57-62.
20. Poon RT-P, Fan S-T, Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. Ann Surg. 2000;232(1):10-24.
21. Sakon M, Nagano H, Nakamori S, et al. Intrahepatic recurrences of hepatocellular carcinoma after hepatectomy: analysis based on tumor hemodynamics. Arch Surg. 2002;137(1):94-99.
22. Lui WY, Chau GY, Loong CC, et al. Hepatic segmentectomy for curative resection of primary hepatocellular carcinoma. Arch Surg. 1995;130(10):1090-1097.
23. Lui WY, Chau GY. Operative approaches to hepatocellular carcinoma in the cirrhotic patient. In: Wanebo HJ, ed. Surgery for Gastrointestinal Cancer: A Multidisciplinary Approach. Philadelphia, PA: Lippincott-Raven; 1997:533-539.
24. Ichida F, Tsuji T, Omata M, et al. New Inuyama classification: new criteria for histological assessment of chronic hepatitis. Int Hepatol Commun. 1996;6(2):112-119.
25. Liver Cancer Study Group of Japan. General Rules for the Clinical and Pathological Study of Primary Liver Cancer. 2nd ed. Tokyo, Japan: Kanehara & Co Ltd; 2003.
26. Ryu M, Watanabe K, Yamamoto H. Hepatectomy with microwave tissue coagulation for hepatocellular carcinoma. J Hepatobiliary Pancreat Surg. 1998;5(2):184-191.
27. Oda T, Tsuda H, Scarpa A, Sakamoto M, Hirohashi S. Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma. Cancer Res. 1992;52(13):3674-3678.
28. Oikawa T, Ojima H, Yamasaki S, Takayama T, Hirohashi S, Sakamoto M. Multistep and multicentric development of hepatocellular carcinoma: histological analysis of 980 resected nodules. J Hepatol. 2005;42(2):225-229.
29. Craddock VM. Liver carcinomas induced in rats by single administration of dimethylnitrosamine after partial hepatectomy. J Natl Cancer Inst. 1971;47(4):889-907.
30. Nakajima T, Kojiro M. Angioarchitecture of hepatocellular carcinoma. In: Okuda K, Peters RL, eds. Hepatocellular Carcinoma. Tokyo, Japan: Springer-Verlag; 1987: 105-116.
31. Semela D, Dufour J-F. Angiogenesis and hepatocellular carcinoma. J Hepatol. 2004;41(5):864-880.
32. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma: conclusion of the Barcelona-2000 EASL Conference. J Hepatol. 2001;35(3):421-430.
33. Castells A, Bruix J, Bru C, et al. Treatment of small hepatocellular carcinoma in cirrhotic patients: a cohort study comparing surgical resection and percutaneous ethanol injection. Hepatology. 1993;18(5):1121-1126.
34. Sato M, Watanabe Y, Ueda S, et al. Microwave coagulation therapy for hepatocellular carcinoma. Gastroenterology. 1996;110(5):1507-1514.
35. Wong WS, Patel SC, Cruz FS, Gala KV, Turner AF. Cryosurgery as a treatment for advanced stage hepatocellular carcinoma: results, complications, and alcohol ablation. Cancer. 1998;82(7):1268-1278.
36. Goldberg SN, Gazelle GS, Solbiati L, et al. Ablation of liver tumors using percutaneous RF therapy. AJR Am J Roentgenol. 1998;170(4):1023- 1028.
37. Bolondi L, Sophia S, Siringo S, et al. Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis. Gut. 2001;48(2):251-259.
38. Matsui Y, Okuda Y, Nakagawa M, et al. Effect of hepatocyte volume on energy status in the cirrhotic rat liver. J Gastroenterol Hepatol. 1994;9(6):613-619.
39. Matsui Y, Tu W, Kitade H, et al. Hepatocyte volume as an indicator of hepatic functional reserve in cirrhotic patients with liver tumours. J Gastroenterol Hepatol. 1996;11(6):540-545.